Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Health Canada/BRINEURA

Authorized

STANDARD

BRINEURA

Biomarin International Limited🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: b3fcd7f18640bde8
Company: Biomarin International Limited
Type: Standard

Approval Details

Approval Id: b3fcd7f18640bde8
Drug Approval Canada Name: BRINEURA
Product Name: BRINEURA
Status: Marketed
Status Date: 2019-03-18
Original Market Date: 2019-03-18
Din: 02484013
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intracerebroventricular
Schedule: Prescription , Schedule D
Ahfs: 44:00.00
Atc Original: A16AB17 CERLIPONASE ALFA
Atc Name: a 16 ab 17
Aig Number: 0161050001
Company Name: Biomarin International Limited
Company Address: Shanbally, Ringaskiddy, Cork, Ireland, P43R298
Company Detail Path: /organization/biomarin-international-limited

Company Information

Pharmaceutical Company Name: Biomarin International Limited
Country Name: Australia

Active Ingredients

CERLIPONASE ALFA

150 MG / 5 ML

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

b3fcd7f18640bde8

Type

Standard

Back to Health Canada Approvals

BRINEURA - Health Canada Drug Approval Details